Image of A n open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain

LITERATURE

A n open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain


Studies of pregabalin for the treatment of central neuropathic pain have been limited to double-blind trials of 4–17 weeks in duration. The purpose of this study was to assess the long-term safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. The efficacy of pregabalin was also assessed as a secondary measure.


Availability

PGB-001Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Journal of Pain Research 2014:7 439–447
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous